Prof. Dr. Georg Schmidt is a Professor of Biosignal Processing at the TUM School of Medicine and Health (Technical University of Munich). His research focuses on non-invasive cardiac risk assessment using electrocardiography (ECG) and heart rate variability (HRV) analysis, with emphasis on mortality prediction, arrhythmia detection, and telemedicine integration. He leads major studies like the EU-CERT-ICD cohort and the German National Cohort (NAKO), exploring topics such as ICD efficacy, gestational diabetes impacts, and data protection standards in healthcare. Key affiliations: TUM School of Medicine and Health, Department of Biosignal Processing Leadership roles: Humboldt/Heisenberg Professorship eligibility (per faculty listings) Research interests include: Cardiac autonomic function and arrhythmia risk ECG-based biomarkers for mortality prediction Interoperability of medical devices in smart hospitals Ethical frameworks for secondary use of health data Publications highlight contributions to ICD therapy optimization, fetal cardiac monitoring, and telemedicine in post-COVID scenarios. His work bridges clinical cardiology with engineering innovations in biosignal analysis. Awards: Not explicitly mentioned in provided texts. Advising/Grants: No listed students, but leads large collaborative research projects. Grants likely tied to EU-CERT-ICD and NAKO initiatives. Labs/Teams: Involved in TUM's biosignal processing and telemedicine integration teams.





